BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19219072)

  • 1. Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.
    Robert I; Aussems M; Keutgens A; Zhang X; Hennuy B; Viatour P; Vanstraelen G; Merville MP; Chapelle JP; de Leval L; Lambert F; Dejardin E; Gothot A; Chariot A
    Oncogene; 2009 Apr; 28(13):1626-38. PubMed ID: 19219072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLL1, a H3K4 methyltransferase, regulates the TNFα-stimulated activation of genes downstream of NF-κB.
    Wang X; Zhu K; Li S; Liao Y; Du R; Zhang X; Shu HB; Guo AY; Li L; Wu M
    J Cell Sci; 2012 Sep; 125(Pt 17):4058-66. PubMed ID: 22623725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.
    Chen Y; Anastassiadis K; Kranz A; Stewart AF; Arndt K; Waskow C; Yokoyama A; Jones K; Neff T; Lee Y; Ernst P
    Cancer Cell; 2017 Jun; 31(6):755-770.e6. PubMed ID: 28609655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression.
    Ansari KI; Mishra BP; Mandal SS
    Biochim Biophys Acta; 2008 Jan; 1779(1):66-73. PubMed ID: 18082152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2.
    Bach C; Mueller D; Buhl S; Garcia-Cuellar MP; Slany RK
    Oncogene; 2009 Feb; 28(6):815-23. PubMed ID: 19060922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.
    Huo H; Magro PG; Pietsch EC; Patel BB; Scotto KW
    Cancer Res; 2010 Nov; 70(21):8726-35. PubMed ID: 20861184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation.
    Nayak A; Viale-Bouroncle S; Morsczeck C; Muller S
    Mol Cell; 2014 Jul; 55(1):47-58. PubMed ID: 24930734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway.
    Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS
    Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 regulates the processing of NF-kappaB2 p100 to p52.
    Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
    EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.
    Denissov S; Hofemeister H; Marks H; Kranz A; Ciotta G; Singh S; Anastassiadis K; Stunnenberg HG; Stewart AF
    Development; 2014 Feb; 141(3):526-37. PubMed ID: 24423662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes.
    Shinsky SA; Hu M; Vought VE; Ng SB; Bamshad MJ; Shendure J; Cosgrove MS
    J Mol Biol; 2014 Jun; 426(12):2283-99. PubMed ID: 24680668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus.
    Demers C; Chaturvedi CP; Ranish JA; Juban G; Lai P; Morle F; Aebersold R; Dilworth FJ; Groudine M; Brand M
    Mol Cell; 2007 Aug; 27(4):573-84. PubMed ID: 17707229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex.
    Weirich S; Kudithipudi S; Jeltsch A
    Mol Oncol; 2017 Apr; 11(4):373-387. PubMed ID: 28182322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2.
    Ishikawa H; Carrasco D; Claudio E; Ryseck RP; Bravo R
    J Exp Med; 1997 Oct; 186(7):999-1014. PubMed ID: 9314550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
    Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52.
    Gustin JA; Korgaonkar CK; Pincheira R; Li Q; Donner DB
    J Biol Chem; 2006 Jun; 281(24):16473-81. PubMed ID: 16613850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
    Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
    Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not All H3K4 Methylations Are Created Equal: Mll2/COMPASS Dependency in Primordial Germ Cell Specification.
    Hu D; Gao X; Cao K; Morgan MA; Mas G; Smith ER; Volk AG; Bartom ET; Crispino JD; Di Croce L; Shilatifard A
    Mol Cell; 2017 Feb; 65(3):460-475.e6. PubMed ID: 28157506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori activates NF-kappaB via the alternative pathway in B lymphocytes.
    Ohmae T; Hirata Y; Maeda S; Shibata W; Yanai A; Ogura K; Yoshida H; Kawabe T; Omata M
    J Immunol; 2005 Dec; 175(11):7162-9. PubMed ID: 16301619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.